Parexel: Growing need to communicate with assorted stakeholders drives medical writing service offering

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Gajus)
(Image: Getty/Gajus)
Parexel’s new medical writing solutions offering will provide communications services throughout the drug development and commercialization process to help sponsors meet higher documentation quality standards, says VP.

According to the Waltham, MA-based contract research organization (CRO), the medical writing solutions team is made up of more than 800 experts around the globe.

“We have seen the drug development journey continue to evolve, with advancements in trial design and technology, changing regulatory requirements, and the growing need to communicate effectively to a multi-faceted audience, including investigators, patients, agencies, and authorities,”​ said Julia Cooper, vice president, head of global medical writing solutions at Parexel.

“As a result, biopharmaceutical companies must have access to highly-experienced medical writers who can communicate with all stakeholders in an integrated way through each critical stage of development and commercialization,”​ she told us.

Cooper explained the new offering will ensure an integrated and streamlined communications strategy across the drug development and commercialization continuum.

“In order to meet product development and commercialization demands, biopharmaceutical companies are increasingly being held to a higher standard of quality documentation,”​ she added.

Earlier this month, Parexel announced​ the appointment of its new CEO, Jamie Macdonald. The company also recently partnered with BioFortis​ to offer biological sample lifecycle management services.  

Related news

Show more

Related products

show more

baxter_bloomington_facility_larger

Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.

lyo_development

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

How will Brexit affect the Pharmaceutical Industry?

How will Brexit affect the Pharmaceutical Industry?

Source BioScience Ltd | 08-Mar-2018 | Technical / White Paper

Have you prepared your strategy for the outcome of Brexit to ensure that you can continue to supply the UK market?
Source BioScience is a CRO with...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

Related suppliers